Inventor
ZHANG GAN
US38 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG GAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARRAY BIOPHARMA INC
12 patentsUS9127013B2Sep 8, 2015
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
ARRAY BIOPHARMA INC47 citations98
US8865698B2Oct 21, 2014
Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
ARRAY BIOPHARMA INC45 citations98
US9676783B2Jun 13, 2017
Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds
ARRAY BIOPHARMA INC23 citations94
US10047097B2Aug 14, 2018
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
ARRAY BIOPHARMA INC9 citations93
US10005783B2Jun 26, 2018
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
ARRAY BIOPHARMA INC10 citations93
US9795611B2Oct 24, 2017
Method of treatment using substituted imidazo[1,2b]pyridazine compounds
ARRAY BIOPHARMA INC15 citations93
US9796723B2Oct 24, 2017
Method of treatment using substituted imidazo[1,2b]pyridazine compounds
ARRAY BIOPHARMA INC15 citations93
US9447104B2Sep 20, 2016
Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
ARRAY BIOPHARMA INC21 citations93
US10011604B2Jul 3, 2018
Method of treatment using substituted imidazo[1,2b]pyridazine compounds
ARRAY BIOPHARMA INC9 citations84
US11267818B2Mar 8, 2022
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
ARRAY BIOPHARMA INC0 citations63
US10774085B2Sep 15, 2020
Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds
ARRAY BIOPHARMA INC0 citations52
US10590139B2Mar 17, 2020
Method of treatment using substituted imidazo[1,2b]pyridazine compounds
ARRAY BIOPHARMA INC0 citations52
UNIV COLORADO REGENTS
5 patentsUS10259846B2Apr 16, 2019
Bouvardin derivatives and therapeutic uses thereof
UNIV COLORADO REGENTS1 citations56
US10508122B2Dec 17, 2019
Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
UNIV COLORADO REGENTS0 citations49
USRE47690ENov 5, 2019
Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
UNIV COLORADO REGENTS0 citations49
US9840520B2Dec 12, 2017
Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
UNIV COLORADO REGENTS0 citations49
US9422340B2Aug 23, 2016
Macrocyclic compounds useful as inhibitors of histone deacetylases
UNIV COLORADO REGENTS0 citations49
AMERICAN HOME PROD
3 patentsUS6239126B1May 29, 2001
Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives
AMERICAN HOME PROD39 citations93
US6306859B1Oct 23, 2001
N-substituted imide derivatives with serotonergic activity
AMERICAN HOME PROD19 citations83
US6326381B1Dec 4, 2001
Arylpiperidine and aryl-1,2,5,6-tetrahydropyidine amide derivates
AMERICAN HOME PROD5 citations74
WYETH CORP
3 patentsUS6503928B2Jan 7, 2003
Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives
WYETH CORP16 citations92
US6638972B2Oct 28, 2003
Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
WYETH CORP28 citations91
US7179813B2Feb 20, 2007
Bicyclic indolyl derivatives and methods for their use as serotonergic agents
WYETH CORP1 citations50